Page 22 of 39 · 913 questions tagged clinical-trials.
The case in front of me: FLOW · reflux · 5 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
Numbers first: SURMOUNT-4 · nausea. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
This is a question about interpretation, not about whether to act — I will take action questions elsewhere. I want to know whether this is a real physical effect or…
Setup, so nobody has to ask: SURMOUNT-1 · a GLP-1 receptor agonist. This has the shape of a fact but I cannot find its origin. What I found instead were three…
Concretely: nausea · liraglutide · SOUL. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics…
The particulars: STEP 4 · ecnoglutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am reasonably comfortable…
Numbers first: PIONEER-4 · hair thinning · 50 mg. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
Concretely: STEP 8 · 2 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the specifics change the…
The case in front of me: STEP 2 · reflux · 60 mg. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
What I have: vomiting · retatrutide · TRIUMPH-1. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Conditions: semaglutide · ATTAIN-1. I want to know whether this is a real physical effect or an artefact of how it is measured. What prompted the question is an…
What I am working with: SURMOUNT-2 · injection-site erythema. I would like help reading this properly rather than being told what conclusion to reach. I have the full…
Details up front: SURPASS-2 · dulaglutide. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence…
What I am working with: REDEFINE-1 · 4 mg. I have read the primary source rather than the summary, which has left me with more questions. I understand the headline. I…
Numbers first: REDEFINE-1 · hair thinning. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Details up front: cagrilintide · retatrutide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible…
Numbers first: SUSTAIN-6 · 2.5 mg. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to disagree,…
The particulars: SUSTAIN-6 · survodutide. I want to understand what this actually establishes, as opposed to what it is being used to imply. My concern is that I am…
Numbers first: a GLP-1 receptor agonist · mazdutide. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a…
Details up front: fatigue · orforglipron · TRIUMPH-1. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone…
Setup, so nobody has to ask: TRIUMPH-1 · reflux · 40 mg. I have read the primary source rather than the summary, which has left me with more questions. I understand…
The specifics, since they change the answer: FLOW · hair thinning. I have the document in front of me and I can read the numbers. What I cannot do is interpret them.…
For reference: liraglutide · tirzepatide. I am trying to choose between two options that are usually discussed as though only one exists. I am not optimising for…
What I have: four weeks · dulaglutide. I am asking for verification rather than opinion, ideally with something I can read myself. It is possible the evidence exists…